What is AstraZeneca Pharma India Price-to-Operating-Cash-Flow?
As of today (2024-05-30), AstraZeneca Pharma India's share price is ₹6366.00.
AstraZeneca Pharma India's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was ₹0.00. Hence, AstraZeneca Pharma India's Price-to-Operating-Cash-Flow Ratio for today is .
The historical rank and industry rank for AstraZeneca Pharma India's Price-to-Operating-Cash-Flow or its related term are showing as below:
BOM:506820'
s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 0 Med: 66.81 Max: 579.43
Current: 571.25
During the past 13 years, AstraZeneca Pharma India's highest Price-to-Operating-Cash-Flow Ratio was 579.43. The lowest was 0.00. And the median was 66.81.
AstraZeneca Pharma India's Cash Flow from Operations per share for the
three
months ended in Mar. 2024 was ₹0.00.
Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was ₹0.00.
During the past 12 months, the average Operating Cash Flow per Share Growth Rate of AstraZeneca Pharma India was -52.20% per year.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -35.70% per year.
During the past 5 years, the average Operating Cash Flow per Share Growth Rate was -12.50% per year.
During the past 13 years, AstraZeneca Pharma India's highest 3-Year average Operating Cash Flow per Share Growth Rate was 128.40% per year. The lowest was -35.70% per year. And the median was 8.20% per year.
AstraZeneca Pharma India Price-to-Operating-Cash-Flow Historical Data
The historical data trend for AstraZeneca Pharma India's Price-to-Operating-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AstraZeneca Pharma India Price-to-Operating-Cash-Flow Chart
|
AstraZeneca Pharma India Annual Data
|
|
Trend |
Mar15 |
Mar16 |
Mar17 |
Mar18 |
Mar19 |
Mar20 |
Mar21 |
Mar22 |
Mar23 |
Mar24 |
| Price-to-Operating-Cash-Flow |
|
Get a 7-Day Free Trial
|
|
|
68.39 |
71.82 |
63.38 |
139.24 |
477.42 |
|
AstraZeneca Pharma India Quarterly Data
|
|
Jun19 |
Sep19 |
Dec19 |
Mar20 |
Jun20 |
Sep20 |
Dec20 |
Mar21 |
Jun21 |
Sep21 |
Dec21 |
Mar22 |
Jun22 |
Sep22 |
Dec22 |
Mar23 |
Jun23 |
Sep23 |
Dec23 |
Mar24 |
| Price-to-Operating-Cash-Flow |
Get a 7-Day Free Trial
|
|
|
|
|
|
|
|
|
|
|
|
|
139.24 |
- |
- |
- |
477.42 |
Competitive Comparison of AstraZeneca Pharma India's Price-to-Operating-Cash-Flow
For the Drug Manufacturers - Specialty & Generic subindustry, AstraZeneca Pharma India's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
AstraZeneca Pharma India's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, AstraZeneca Pharma India's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where AstraZeneca Pharma India's Price-to-Operating-Cash-Flow falls into.
AstraZeneca Pharma India Price-to-Operating-Cash-Flow Calculation
AstraZeneca Pharma India's Price-to-Operating-Cash-Flow ratio for today is calculated as
| Price-to-Operating-Cash-Flow Ratio | = | Share Price | / | Cash Flow from Operations per share (TTM) |
| = | 6366.00 | / | 0 |
| = | |
AstraZeneca Pharma India's Share Price of today is ₹6366.00.
AstraZeneca Pharma India's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.00.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).
It can also be calculated from the numbers for the whole company:
AstraZeneca Pharma India (BOM:506820) Business Description
Traded in Other Exchanges
Address
Outer Ring Road, Block N1, 12th Floor, Manyata Embassy Business Park, Rachenahalli, Bangalore, KA, IND, 560 045
AstraZeneca Pharma India Ltd is engaged in the manufacture, distribution, and marketing of pharmaceutical products. Its only operating segment being Healthcare. The company generates revenue from the sale of products such as Tablets, Injectables, and Inhalation. Geographically, it derives a majority of revenue from India. It focuses on areas such as Cardiovascular, Renal and Metabolism (CVRM), Oncology, Respiratory, Inflammation and Autoimmunity, Neuroscience and Infection and Vaccines.
AstraZeneca Pharma India (BOM:506820) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BOM:506820 has been successfully added to your